COMPOSITIONS AND METHODS FOR TRANSPORT ACROSS THE BLOOD BRAIN BARRIER
First Claim
Patent Images
1. A composition, comprising a peptide comprising a sequence of SEQ ID NO:
- 1.
1 Assignment
0 Petitions
Accused Products
Abstract
Compositions and methods are provided including a transporter peptide derived from the loop2 domain of the neuronally-derived lynx1 protein which can be conjugated to an effector agent to form a transporter-effector complex for transport of the therapeutic effector agent to a target that is found across the blood brain barrier.
-
Citations
26 Claims
- 1. A composition, comprising a peptide comprising a sequence of SEQ ID NO:
-
9. A composition comprising:
a peptide comprising a sequence of SEQ ID NO;
13.- View Dependent Claims (10, 11)
-
12. A method of transporting a peptide composition to a target found within the blood brain barrier, comprising:
providing the peptide composition comprising the sequence of SEQ ID NO;
1 to the target, wherein the target may be in vivo or in vitro.
-
13. A method of transporting an effector agent to a target found within the blood brain barrier, comprising:
-
conjugating a peptide comprising the sequence of SEQ ID NO;
1 to an effector agent to form a complex; andproviding the complex to the target, wherein the target may be in vivo or in vitro. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20, 21, 22, 23)
-
-
24. A method of transporting a peptide composition to a target found within the blood brain barrier, comprising:
providing the peptide composition comprising the sequence of SEQ ID NO;
13 to the target, wherein the target may be in vivo or in vitro.
-
25. A method of transporting an effector agent to a target found within the blood brain barrier, comprising:
-
conjugating a peptide comprising a sequence of SEQ ID NO;
13 to an effector agent to form a complex; andproviding the complex to the target, wherein the target may be in vivo or in vitro. - View Dependent Claims (26)
-
Specification